The study aimed to test the anti-tumor effects of a specific antibody, Met scFv, on lung adenocarcinoma tumors implanted in nude mice.
Researchers created tumors by injecting A549 cancer cells into the mice, then tracked the antibody's distribution in the mice using imaging techniques after administering the antibody.
Results showed that the Met scFv antibody effectively targeted the tumor cells and significantly inhibited tumor growth, indicating its potential as a cancer treatment.